GSK5533524 clinical trials

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

This study is testing a new drug, GSK5533524, for advanced cancers. Researchers want to find a safe dose, check for side effects, and see if it can shrink tumours or slow their growth in adults who have tried other treatments.